Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Renal Impairment

Interventions

DRUG

BPN14770

BPN14770 will be administered per schedule specified in the arm description.

Trial Locations (2)

RECRUITING

Orlando Clinical Research Center, Orlando

RECRUITING

Division of Clinical Pharmacology, University of Miami, Miami